相关实验视频

Updated: Jan 14, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

高脂蛋白在初级和二级预防中的临床意义:一个多机构研究

Dong-Yi Chen^1,2,3, Ming-Lung Tsai^4,5, Ming-Jer Hsieh^1,4

¹Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taiwan.

European journal of preventive cardiology

|October 22, 2025

概括

升高的脂蛋白[Lp]水平,特别是30 mg/dL或更高的水平,显著增加了主要不良心血管事件 (MACE) 的风险. 这一发现适用于具有或没有先前存在的动脉样硬化心血管疾病 (ASCVD) 的个人.

科学领域:

心脏病学心脏病学
生物化学生物化学
流行病学流行病学

背景情况:

升高的脂蛋白[Lp[a]越来越被认为是动脉样硬化心血管疾病 (ASCVD) 的因果因素.
对于Lp (a) 度值,如30 mg/dL,对于风险分层的具体临床效用需要进一步研究.

研究的目的:

调查台湾人群中Lp(a) 度与心血管结果之间的关联.
为了评估30 mg/dL的Lp (a) 水平对主要不良心血管事件 (MACE) 的预测值,在按ASCVD状态分层的个体中.

主要方法:

从长光研究数据库 (2004-2019) 中回顾分析了51,934名个人.
分为具有和没有确定的ASCVD (2571名和49363名受试者分别) 的分层.
主要终点:MACE,包括心肌梗塞,中风,再血管化和心血管死亡率,随访至2019年12月31日.

主要成果:

中位数Lp(a) 水平为9.6 mg/dL;平均随访时间为6.6年.
在没有ASCVD的个体中,Lp (a) ≥30 mg/dL与MACE风险增加有关 (aSHR:1.24;95%CI:1.07-1.43).
在ASCVD队列中,升高的Lp (a) 也预测了更高的MACE发生率 (aSHR: 1.36;95% CI: 1.07-1.74);风险逐渐增加超过30 mg/dL.

结论:

Lp (a) 水平≥30 mg/dL是心血管不良结果的独立预测指标.
这个30mg/dL的门值在初级和二级预防环境中对心血管风险分层是有效的.

关键词:

心血管疾病心血管疾病脂蛋白 (a) 是一种蛋白质心肌梗塞的心脏病发作首要预防首要预防二次预防二次预防.

更多相关视频

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

相关概念视频

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...